NCT05977699 - Reversibility of Methacholine Induced Bronchoconstriction | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions

Asthma

Interventions

DRUG

salbutamol aqueous solution

administration of 200microliters of salbutamol to reverse methacholine induced bronchoconstriction using a vibrating mesh nebulizer

DRUG

salbutamol pressurized metered dose inhaler

administration of 200microliters of salbutamol to reverse methacholine induced bronchoconstriction using a pressurized metered dose inhaler plus spacer

OTHER

placebo

matching placebo delivered via pressurized metered dose inhaler plus spacer or normal saline via vibrating mesh nebulizer

Trial Locations (1)

S7N 0W8

Asthma Research Lab University of Saskatchewan Room 346 Ellis Hall, Saskatoon

All Listed Sponsors

lead

University of Saskatchewan

OTHER